FDAnews
www.fdanews.com/articles/124329-pfizer-qiagen-rsquo-s-dxs-to-develop-companion-diagnostic-for-brain-tumor-patients

Pfizer, Qiagen’s DxS to Develop Companion Diagnostic for Brain Tumor Patients

February 5, 2010
Pharmaceutical company Pfizer Inc and DxS, a subsidiary of QIAGEN N.V., said that they have entered into an agreement to develop a companion diagnostic test kit for PF-04948568 (CDX-110).
TradingMarkets